ArticleJournal of the advanced practitioner in oncology2025
Evaluating the Use of Recommended Screening and Preventive Practices for Adult Allogeneic Transplant Patient Survivors Performed by Advanced Practice Providers.
Article in Journal of the advanced practitioner in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The purpose of this quality improvement project was to evaluate the use of a posttransplant screening care guidelines template performed by advanced practice providers (APPs) that included standards of care and published recommendations from the American Society for Transplantation and Cellular Therapy (ASTCT) for adult allogeneic transplant patient survivors. Methods: The theoretical framework used for this project was the Model for Improvement with the Plan-Do-Study-Act (PDSA) cycle process. A screening template was built to include institutional standards of care and recommendations from the ASTCT's guidelines within the electronic medical record system for APP use. Weekly chart reviews were performed for data extraction and assessment for APP documentation and completion of day +30 and day +100 posttransplant recommended screenings/testing. Data were documented and tracked utilizing Excel securely over a 3-month period. Results: The APPs performed and documented the recommended screenings for 64% of patients at day +30 and for 80% of patients at day +100. Opportunities for unit and system improvements were identified to increase performance, expand utilization, allow clinicians to recognize complications earlier, and potentially improve patient outcomes. Conclusion: This project addresses implications for APP care delivery and patient outcomes. Future project cycles' success will be ensured by utilizing the APP role at the maximum scope of practice.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.